[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

IMNM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 20.00%

Insider Buying (Last 12 Months): $1,249,988.64

Insider Selling (Last 12 Months): $0.00

Immunome Insider Trading History Chart

Immunome Share Price & Price History

^$7.73

▲ +0.03 (0.39%)

As of 12/8/2023 01:00 AM ET

Days: 30 | 90 | 365

Trading Experts Call It “The Perfect Tesla Trade”

From Wealthpress | Ad

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

Click here for details,

Immunome Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/2/2023	Bruce Turner	Insider	Buy	42,300	$5.91	$249,993.00	42,300
10/2/2023	Clay B Siegall	CEO	Buy	169,204	$5.91	$999,995.64	319,636
9/13/2021	Michael Rapp	Director	Buy	25,962	$19.96	$518,201.52	799,866
9/9/2021	Michael Rapp	Director	Buy	30,450	$18.19	$553,885.50	799,866
5/26/2021	Michael Lefenfeld	Director	Buy	1,335	$19.03	$25,405.05	22,822
5/25/2021	Purnanand D. Sarma	CEO	Buy	10,500	$18.41	$193,305.00	10,500
5/24/2021	Michael Lefenfeld	Director	Buy	600	$17.80	$10,680.00	46,726

Trading Experts Call It “The Perfect Tesla Trade”

From Wealthpress | Ad

Click here for details,

SEC Filings (Institutional Ownership Changes) for Immunome (NASDAQ:IMNM)

37.76% of Immunome stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Immunome Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2023	The Manufacturers Life Insurance Company	53,746	$0.45M	0.0%	N/A	0.441%
11/14/2023	Schonfeld Strategic Advisors LLC	18,201	$0.15M	0.0%	N/A	0.149%
11/13/2023	Acadian Asset Management LLC	49,712	$0.41M	0.0%	N/A	0.407%
11/8/2023	HighTower Advisors LLC	18,818	$0.16M	0.0%	+19.0%	0.154%
11/7/2023	Dorsey Wright & Associates	3,100	$26K	0.0%	N/A	0.025%
10/27/2023	TD Asset Management Inc	127,280	$1.06M	0.0%	N/A	1.043%
8/15/2023	Point72 Asset Management L.P.	418,127	$3.31M	0.0%	N/A	3.427%
8/15/2023	Prentice Capital Management LP	112,131	$0.89M	2.8%	-74.0%	0.919%
8/14/2023	Cerity Partners LLC	67,126	$0.53M	0.0%	+25.8%	0.550%
8/11/2023	Renaissance Technologies LLC	44,500	$0.35M	0.0%	+54.0%	0.364%
8/11/2023	BlackRock Inc.	43,312	$0.34M	0.0%	+4.3%	0.355%
8/2/2023	Bank of Montreal Can	100,334	$0.80M	0.0%	N/A	0.822%
7/12/2023	Heron Bay Capital Management	13,139	$0.10M	0.0%	N/A	0.108%
5/16/2023	Prentice Capital Management LP	431,904	$2.16M	4.6%	-13.3%	3.536%
5/12/2023	Renaissance Technologies LLC	28,900	$0.14M	0.0%	+37.0%	0.237%
5/12/2023	Dimensional Fund Advisors LP	15,433	$77K	0.0%	N/A	0.126%
5/12/2023	HighTower Advisors LLC	16,818	$83K	0.0%	N/A	0.138%
2/15/2023	Cerity Partners LLC	53,347	$0.12M	0.0%	-6.3%	0.440%
2/14/2023	Susquehanna International Group LLP	22,064	$49K	0.0%	-9.2%	0.182%
2/13/2023	Natixis	11,000	$25K	0.0%	N/A	0.091%
11/15/2022	Vanguard Group Inc.	373,685	$1.66M	0.0%	+0.8%	3.081%
11/10/2022	UBS Group AG	15,271	$68K	0.0%	+1,049.9%	0.126%
8/13/2022	Renaissance Technologies LLC	21,500	$69K	0.0%	+53.6%	0.177%
8/10/2022	Cerity Partners LLC	56,962	$0.18M	0.0%	-39.1%	0.470%
5/17/2022	Prentice Capital Management LP	792,321	$4.50M	1.1%	-1.8%	6.532%
5/17/2022	First Republic Investment Management Inc.	15,270	$87K	0.0%	N/A	0.126%
5/13/2022	Renaissance Technologies LLC	14,000	$80K	0.0%	N/A	0.115%
5/13/2022	Vanguard Group Inc.	370,536	$2.11M	0.0%	-1.5%	3.055%
11/16/2021	Baldwin Investment Management LLC	9,196	$0.22M	0.0%	N/A	0.076%
11/15/2021	Marshall Wace LLP	8,348	$0.20M	0.0%	N/A	0.069%
11/12/2021	Geode Capital Management LLC	54,669	$1.33M	0.0%	+38.3%	0.452%
11/10/2021	HAP Trading LLC	17,922	$0.44M	0.0%	N/A	0.148%
11/9/2021	BlackRock Inc.	40,508	$0.99M	0.0%	+77.0%	0.335%
10/25/2021	Cerity Partners LLC	102,004	$2.48M	0.1%	-2.4%	0.843%
10/20/2021	Ridgewood Investments LLC	28,013	$0.68M	0.5%	-51.7%	0.232%
8/16/2021	Royal Bank of Canada	28,127	$0.49M	0.0%	+8,271.1%	0.239%
8/16/2021	Morgan Stanley	11,371	$0.20M	0.0%	+9,375.8%	0.097%
8/13/2021	Renaissance Technologies LLC	20,400	$0.35M	0.0%	N/A	0.174%
8/13/2021	Alpine Global Management LLC	854,671	$14.79M	2.0%	+7.4%	7.269%
8/13/2021	Neuberger Berman Group LLC	19,444	$0.34M	0.0%	N/A	0.165%
8/13/2021	Geode Capital Management LLC	39,529	$0.68M	0.0%	-19.9%	0.336%
8/13/2021	Vanguard Group Inc.	302,092	$5.23M	0.0%	+95.9%	2.569%
8/12/2021	Ergoteles LLC	10,006	$0.17M	0.0%	N/A	0.085%
8/9/2021	Wealth Architects LLC	11,201	$0.19M	0.0%	N/A	0.095%
8/6/2021	Magnus Financial Group LLC	25,759	$0.45M	0.1%	+75.9%	0.219%
7/31/2021	Sterling Investment Advisors Ltd.	21,627	$0.37M	0.1%	N/A	0.184%
7/31/2021	Ridgewood Investments LLC	58,013	$1M	0.6%	N/A	0.493%
5/18/2021	Prentice Capital Management LP	331,995	$11.25M	3.5%	-20.3%	2.824%
5/14/2021	O Shaughnessy Asset Management LLC	1,599	$54K	0.0%	N/A	0.015%
5/13/2021	Alpine Global Management LLC	795,709	$26.96M	2.6%	+0.7%	7.464%
5/12/2021	Northern Trust Corp	27,114	$0.92M	0.0%	+7.2%	0.254%
5/12/2021	Cerity Partners LLC	110,327	$3.74M	0.1%	-10.0%	1.035%
5/12/2021	Geode Capital Management LLC	49,331	$1.67M	0.0%	+225.0%	0.463%
5/11/2021	New York State Common Retirement Fund	3,650	$0.12M	0.0%	-33.0%	0.034%
5/7/2021	BlackRock Inc.	112,851	$3.82M	0.0%	+57.3%	1.059%
5/5/2021	Magnus Financial Group LLC	14,648	$0.50M	0.1%	N/A	0.137%
4/23/2021	Strs Ohio	1,400	$47K	0.0%	N/A	0.013%
2/19/2021	JPMorgan Chase & Co.	5,731	$55K	0.0%	N/A	0.054%
2/12/2021	Prentice Capital Management LP	416,667	$4.03M	1.1%	N/A	3.952%
2/12/2021	Kepos Capital LP	66,666	$0.65M	0.1%	N/A	0.632%
2/11/2021	Northern Trust Corp	25,287	$0.25M	0.0%	N/A	0.240%
2/11/2021	Cerity Partners LLC	122,546	$1.19M	0.0%	N/A	1.162%
2/8/2021	New York State Common Retirement Fund	5,450	$53K	0.0%	N/A	0.052%
2/6/2021	Granite Point Capital Management L.P.	66,666	$0.65M	0.0%	N/A	0.632%
2/5/2021	BlackRock Inc.	71,752	$0.70M	0.0%	N/A	0.681%

Data available starting January 2016

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01 that targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.

Today's Range

Now: $7.73

$7.54

$7.87

50 Day Range

MA: $8.22

$7.46

$8.99

52 Week Range

Now: $7.73

$2.20

$9.53

Volume

97,215 shs

Average Volume

99,453 shs

Market Capitalization

$330.30 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.42

Who are the company insiders with the largest holdings of Immunome?: Immunome's top insider shareholders include:
Clay B Siegall (CEO)
Bruce Turner (Insider)
Learn More about top insider investors at Immunome.
Who are the major institutional investors of Immunome?: Immunome's top institutional investors include:
TD Asset Management Inc — 1.04%
The Manufacturers Life Insurance Company — 0.44%
Acadian Asset Management LLC — 0.41%
HighTower Advisors LLC — 0.15%
Schonfeld Strategic Advisors LLC — 0.15%
Dorsey Wright & Associates — 0.03%
Learn More about top institutional investors of Immunome stock.
Which institutional investors are selling Immunome stock?: During the previous quarter, IMNM stock was sold by these institutional investors:
Simplex Trading LLC
Cutler Group LLC CA
Which institutional investors are buying Immunome stock?: In the previous quarter, IMNM stock was acquired by institutional investors including:
TD Asset Management Inc
The Manufacturers Life Insurance Company
Acadian Asset Management LLC
Schonfeld Strategic Advisors LLC
Dorsey Wright & Associates
HighTower Advisors LLC
Within the previous year, these company insiders have bought Immunome stock:
Clay B Siegall (CEO)
Bruce Turner (Insider)
Learn More investors buying Immunome stock.